Cargando…

The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer

The approval of targeted therapies for metastatic colorectal cancer (mCRC) has led to important improvements in patient outcomes. However, it is still necessary to increase individualisation of treatments based on tumour genetic profiles to optimise efficacy, while minimising toxicity. As such, ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taieb, Julien, Jung, Andreas, Sartore-Bianchi, Andrea, Peeters, Marc, Seligmann, Jenny, Zaanan, Aziz, Burdon, Peter, Montagut, Clara, Laurent-Puig, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728290/ https://www.ncbi.nlm.nih.gov/pubmed/31347092 http://dx.doi.org/10.1007/s40265-019-01165-2

Ejemplares similares

Exploring the best treatment options for BRAF-mutant metastatic colon cancer
por: Taieb, Julien, et al.
Publicado: (2019)

Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives
por: Moati, Emilie, et al.
Publicado: (2021)

Comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'
por: Tougeron, D, et al.
Publicado: (2014)

Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer
por: Goldberg, Richard M, et al.
Publicado: (2018)

The Evolutionary Landscape of Treatment for BRAF(V600E) Mutant Metastatic Colorectal Cancer
por: Mauri, Gianluca, et al.
Publicado: (2021)

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer
por: Siena, Salvatore, et al.
Publicado: (2009)

Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials
por: Peeters, Marc, et al.
Publicado: (2018)

The Evolving Treatment Landscape for Metastatic Differentiated Thyroid Cancer
por: Grande, Carolyn, et al.
Publicado: (2014)

The Evolving Landscape of Myelodysplastic Syndrome Prognostication
por: Shreve, Jacob, et al.
Publicado: (2020)

The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
por: Studentova, Hana, et al.
Publicado: (2023)

Bidirectional chemotherapy combining intraperitoneal docetaxel with intravenous 5-fluorouracil and oxaliplatin for patients with unresectable peritoneal metastasis from gastric cancer: the first study in Western countries
por: Lo Dico, Rea, et al.
Publicado: (2020)

Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon Cancers
por: Bayle, Arnaud, et al.
Publicado: (2021)

FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
por: Zaanan, Aziz, et al.
Publicado: (2014)

Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer
por: Cremolini, Chiara, et al.
Publicado: (2023)

Ampullary carcinoma prognostic markers
por: Perkins, Geraldine, et al.
Publicado: (2019)

Strategies to tackle RAS-mutated metastatic colorectal cancer
por: Patelli, G., et al.
Publicado: (2021)

ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
por: Zaanan, Aziz, et al.
Publicado: (2014)

Genomic landscape of metastatic colorectal cancer
por: Haan, Josien C., et al.
Publicado: (2014)

Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic Landscape
por: Hall, Mary E, et al.
Publicado: (2020)

Rapidly Evolving Treatment Landscape for Metastatic Esophagogastric Carcinoma: Review of Recent Data
por: Kankeu Fonkoua, Lionel Aurelien, et al.
Publicado: (2021)

The Evolving Landscape of Biomarkers in Celiac Disease: Leading the Way to Clinical Development
por: Smithson, Glennda, et al.
Publicado: (2021)

The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions
por: Pagès, Franck, et al.
Publicado: (2020)

Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
por: Amodio, Vito, et al.
Publicado: (2021)

A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer
por: Tinker, Anna V., et al.
Publicado: (2023)

Challenges in the Evolving CME Landscape
por: Gillgrass, Darren
Publicado: (2020)

Cervical screening: the evolving landscape
por: Davies-Oliveira, Jennifer C, et al.
Publicado: (2022)

Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies
por: Russo, Mariangela, et al.
Publicado: (2018)

Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial
por: Anota, Amélie, et al.
Publicado: (2015)

Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches
por: Li, Furong, et al.
Publicado: (2023)

The evolving landscape of predictive biomarkers in immuno‐oncology with a focus on spatial technologies
por: Sadeghi Rad, Habib, et al.
Publicado: (2020)

Editorial: The Evolving Landscape, Clinical Implications, and Future Perspective of Biomarkers in Gastrointestinal Cancers
por: Tsai, Hsiang-Lin, et al.
Publicado: (2022)

Evolving landscape in the management of transthyretin amyloidosis
por: Hawkins, Philip N., et al.
Publicado: (2015)

The evolving landscape in advanced penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2015)

Evolving generalists in switching rugged landscapes
por: Wang, Shenshen, et al.
Publicado: (2019)

The Evolving Landscape of Cardiovascular Disease Prevention
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2021)

The Evolving Landscape of Fecal Microbial Transplantation
por: Shao, Tihong, et al.
Publicado: (2023)

The evolving landscape of thoracic surgical oncology
por: Kim, Anthony W., et al.
Publicado: (2023)

The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy
por: Tunger, Antje, et al.
Publicado: (2019)

From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct
por: González-Gascón-y-Marín, Isabel, et al.
Publicado: (2021)

Crop pathogen emergence and evolution in agro-ecological landscapes
por: Papaïx, Julien, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bvpphidacfkotjlp2cgd5un1jq